These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19074003)

  • 21. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men.
    Gu YQ; Tong JS; Ma DZ; Wang XH; Yuan D; Tang WH; Bremner WJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2254-62. PubMed ID: 15126550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.
    Cherrier MM; Anawalt BD; Herbst KL; Amory JK; Craft S; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3090-6. PubMed ID: 12107206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
    Misro MM; Chaki SP; Kaushik MC; Nandan D
    Contraception; 2009 Jun; 79(6):488-97. PubMed ID: 19442786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.
    Meriggiola MC; Costantino A; Saad F; D'Emidio L; Morselli Labate AM; Bertaccini A; Bremner WJ; Rudolph I; Ernst M; Kirsch B; Martorana G; Pelusi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2005-14. PubMed ID: 15634716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid hormones for contraception in men.
    Grimes DA; Lopez LM; Gallo MF; Halpern V; Nanda K; Schulz KF
    Cochrane Database Syst Rev; 2012 Mar; (3):CD004316. PubMed ID: 22419294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct effect of progestogen on gene expression in the testis during gonadotropin withdrawal and early suppression of spermatogenesis.
    Walton MJ; Bayne RA; Wallace I; Baird DT; Anderson RA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2526-33. PubMed ID: 16621906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.
    Meriggiola MC; Costantino A; Cerpolini S; Bremner WJ; Huebler D; Morselli-Labate AM; Kirsch B; Bertaccini A; Pelusi C; Pelusi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5818-26. PubMed ID: 14671175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.
    Gu YQ; Wang XH; Xu D; Peng L; Cheng LF; Huang MK; Huang ZJ; Zhang GY
    J Clin Endocrinol Metab; 2003 Feb; 88(2):562-8. PubMed ID: 12574181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
    Johnson L; Barnard JJ; Rodriguez L; Smith EC; Swerdloff RS; Wang XH; Wang C
    J Androl; 1998; 19(3):348-57. PubMed ID: 9639052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development.
    Lue Y; Hikim AP; Wang C; Im M; Leung A; Swerdloff RS
    Endocrinology; 2000 Apr; 141(4):1414-24. PubMed ID: 10746645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fold-change correction values for testicular somatic transcripts in gene expression studies of human spermatogenesis.
    Cappallo-Obermann H; Feig C; Schulze W; Spiess AN
    Hum Reprod; 2013 Mar; 28(3):590-8. PubMed ID: 23303554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
    McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non-human primate study (baboon; Papio hamadryas) to determine if a long-acting progestogen, levonorgestrel butanoate, combined with a long-acting androgen, testosterone buciclate, can suppress spermatogenesis: II. Efficacy study.
    Goncharov NP; Katzia GV; Butnev VU; Gorlushkin VM; Waites GM
    Int J Androl; 1995 Apr; 18(2):83-7. PubMed ID: 7665214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of injection of testosterone undecanoate and depot medroxyprogesterone acetate on the suppression of spermatogenesis].
    Tang W; Gu Y; Tong J; Ma D; Wang X; Yuan D; Chen Z; Bremner WJ
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):572-7, 581. PubMed ID: 15362516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.